Skip to main content
Home Start-Ups Page 10

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/05/tune-tx-nph-announcement-featured-image.png

Tune Therapeutics Unveils Breakthrough Data Showing Stable and Durable Epigenetic Regulation in Non-Human Primates

Tune Therapeutics is a Duke University start-up developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/05/Reselute-DuCap-investment-PR-featured-image.jpg

Duke Capital Partners Leads Investment in Reselute

Reselute, founded around Duke technology by a Duke professor and graduates, is developing solutions to orthopedic infections

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/05/Katy-Digovich-Minutia-TEDx-talk.png

Can I cure my diabetes with stem cells? Minutia TEDx talk

Minutia is a next generation cell therapy start-up co-founded by Professor Tuan Vo-Dinh (BME, Pratt), in part based on tech developed in his lab.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/05/Screen-Shot-2023-05-03-at-10.47.17-AM.png

Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models

Ten63 is a Duke University start-up founded by Professor Bruce Donald (Computer Science, Trinity), and his students. Ten63 is also a Duke Capital Partners portfolio company.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/04/Ai-RGUS-logo.jpeg

Ai-RGUS wins Security Industry Association award

Ai-RGUS is a Duke start-up spun up from technology developed by Drs. Jordan Malof, Leslie Collins, Joseph Camilo, and Daniel Reichman (ECE, Pratt).

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/04/ELN-2023-cohort-announcement.png

Duke Entrepreneurial Leaders Network Announces New Cohort

ELN, a select group of Duke alumni who are committed to founding or leading an innovation-drive startup, has announced its 2023 cohort.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/04/tune_logo-FULL.jpeg

Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel

Tune Therapeutics is an epigenomic editing start-up spun out of the lab of Dr. Charles Gersbach (BME, Pratt).

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/03/lacuna-medical-ducap-fundraise-pr-featured.png

Duke Capital Partners Leads Investment in Lacuna Medical

Lacuna Medical is Developing a 3D Shape Catheter that is More Resistant to Failure

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/03/evecxia-logo.png

Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single Ascending Dose Safety/Tolerability/PK/PD Trial of EVX-301

Evecxia Therapeutics is a Duke University start-up, founded by inventors Drs. Jacob Jacobsen and Marc Caron (Cell Biology, SOM) around their serotonin synthesis amplification therapeutic technology for mental health applications.

Read More

1 8 9 10 11 12 36